Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Corn

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44363   clinical trials with a EudraCT protocol, of which   7387   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    9 result(s) found for: Corn. Displaying page 1 of 1.
    EudraCT Number: 2008-005313-21 Sponsor Protocol Number: PB-PG 0807-14060 Start Date*: 2009-05-19
    Sponsor Name:Sheffield Health and Social Research Consortium
    Full Title: The long term effectiveness of 40% salicylic acid plasters on corns
    Medical condition: Corns
    Disease: Version SOC Term Classification Code Term Level
    9.1 10011064 Corns LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-003445-17 Sponsor Protocol Number: BBG001 Start Date*: 2009-05-12
    Sponsor Name:Queen Mary, University of London
    Full Title: The probiotic Bifidobacterium breve strain BBG-01 admistered early to preterm infants to prevent infection, necrotising enterocolitis and death.
    Medical condition: Necrotising enterocolitis in the preterm baby Late-onset (>72h of age) blood stream infection in the preterm baby Death of preterm babies before discharge from hospital
    Disease:
    Population Age: Preterm newborn infants, Newborns, Under 18 Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-000729-24 Sponsor Protocol Number: 1821 Start Date*: 2007-05-15
    Sponsor Name:University Hospital Linköping
    Full Title: Coagulation effect of four common plasma volume expanders
    Medical condition: Fluid/Plasma substitution during total hip replacement
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-005920-16 Sponsor Protocol Number: CHUB-930105 Start Date*: 2012-02-06
    Sponsor Name:Association Hospitalière CHU Brugmann
    Full Title: Prospective, controled, randomized, double blind monocentric study evaluating the efficacy of the basic component of colloids (corn versus potato) on perioperative blood losses in elective cardiac ...
    Medical condition: Elective cardiac surgery
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2007-002122-30 Sponsor Protocol Number: 1978 Start Date*: 2007-09-14
    Sponsor Name:Medical University Vienna Division of Anesthesie and Pain Management
    Full Title: The effect of different solvents of HES preparations on coagulation and platelet function (Effekt der Trägerlösung von HES Präparaten auf Blutgerinnung und Thrombozytenfunktion)
    Medical condition: treatment and prophylaxis of acute hypovolaemia and shock acute normovolaemic haemodilution
    Disease: Version SOC Term Classification Code Term Level
    9.1 10021139 Hypovolemia LLT
    9.1 10011954 Decreased and nonspecific blood pressure disorders and shock HLGT
    9.1 10059489 Hemodilution LLT
    Population Age: Adults Gender: Male
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2006-004720-37 Sponsor Protocol Number: Voluven_v1.0fr Start Date*: 2006-12-11
    Sponsor Name:CUB Hôpital Erasme, Department of Anesthesiology
    Full Title: Effect of Voluven on postoperative morbidity after gynaecological surgery
    Medical condition: Healthy female patients (American Society of Anaesthesiologists score I or II) programmed for elective gynaecological surgery and at least 18 years old
    Disease: Version SOC Term Classification Code Term Level
    8.1 10054182 Perioperative nausea and vomiting prophylaxis LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2004-002070-36 Sponsor Protocol Number: GLU-005 Start Date*: 2004-12-22
    Sponsor Name:Metcon Medicin AB
    Full Title: Efficacy of MM005-Granulae as prophylaxis for nocturnal hypoglycemia in insulin treated Type 1 diabetic subjects. A double-blind, randomized, placebo-controlled phase II multi-center study in three...
    Medical condition: Diabetes type I
    Disease: Version SOC Term Classification Code Term Level
    6,1 10045228 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2020-001939-27 Sponsor Protocol Number: SystABSinus01 Start Date*: 2021-02-25
    Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Zahn-, Mund- und Kieferheilkunde
    Full Title: The effect of systemic antibiotics on post-surgical complications and patient-centered outcomes in patients undergoing implant surgery with guided bone regeneration and simultaneous sinus floor ele...
    Medical condition: patients undergoing oral implant therapy with simultaneous lateral sinus floor elevation and guided bone regeneration (GBR)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2021-001885-40 Sponsor Protocol Number: Syst-AB+Sinus Start Date*: 2022-02-24
    Sponsor Name:Universidad Complutense de Madrid
    Full Title: The effect of systemic antibiotics on post-surgical complications and paitent-centered outomes in patients undergoing implant surgery with the guided bone regeneration and simultaneous sinus floor ...
    Medical condition: The medical condition that the patients have in this trial is edentulism in a posterior maxillary quadrant of the mouth with a sinus pneumatisation/ decreased crestal bone heigh defect requiring a...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Tue Nov 04 11:23:14 CET 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA